SECUKINUMAB REDUCES SPINAL INFLAMMATION AS EARLY AS WEEK 6, AS DETECTED BY MRI - RESULTS OF A DOUBLE-BLIND, PHASE II PROOF-OF-CONCEPT STUDY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
Author(s):
Baraliakos, X.; Braun, J.; Laurent, D.D.; Baeten, D.; Heijde, D. van der; Sieper, J.; Emery, P.; McInnes, I.; Laar, J. van; Landewe, R.; Wordsworth, P.; Wollenhaupt, J.; Kellner, H.; Wright, A.M.; Gsteiger, S.; Hueber, W.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-08-31
Language
English
Is part of
Clinical and Experimental Rheumatology (2012), Vol. 30, no. 4, p. 632-632
